New study aims to sharpen tools for tracking becker muscular dystrophy
NCT ID NCT05257473
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This 24-month observational study will follow 80 people with Becker muscular dystrophy (BMD) to better understand how the disease progresses. Researchers will measure muscle strength, walking speed, breathing, and heart function using standard tests. The goal is to identify which tests are most useful for tracking BMD in future clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could identify the most reliable ways to measure disease progression in Becker muscular dystrophy, helping design better future treatment trials.
What could go wrong
This is an observational study, not a treatment trial. It will not test any therapy, and the findings may not apply to all patients or lead directly to new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BECKER MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
John Walton Muscular Dystrophy Research Centre
Newcastle upon Tyne, NE1 4EP, United Kingdom
-
Kennedy Krieger Institute
Baltimore, Maryland, 21205, United States
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
-
University of Auckland
Auckland, New Zealand
-
University of California, Irvine
Orange, California, 92868, United States
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States